Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03943368 · ClinicalTrials.gov registry record · NA

Using Virtual Reality (VR) Models for Robotic Prostatectomy

A NA study of Prostate Cancer, sponsored by Ceevra.

Completed
Registry status
NA
Development phase
92
Enrollment target
6
Study locations

NCT03943368: Completed NA study of Prostate Cancer, sponsored by Ceevra.

NCT03943368 is a NA study of Prostate Cancer that has completed, run by Ceevra. The registered enrollment target is 92 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (85% lower). The trial reports 6 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03943368, a NA study of Prostate Cancer, has completed, sponsored by Ceevra.

COMPLETED
Registry status
NA
Development phase
92 participants
Enrollment target
6
Study locations

Study Summary

A prospective, randomized, controlled study designed to assess whether digital virtual reality (VR) models, created from existing CT scans and MRIs, provide surgeons with an improved understanding of their patients' anatomy, resulting in more efficient operations (robotic prostatectomy) and improved patient care.

Conditions Studied

Interventions

  • DEVICE Ceevra Reveal

Study Locations (6)

California

  • UCLA Urology - Los Angeles
  • UC Irvine - Orange

Washington

  • Swedish Urology Group - Seattle
  • Swedish Medical Center - Seattle

Florida

  • Mayo Clinic Florida - Jacksonville

New York

  • Mount Sinai Health System - New York

Trial Details

FieldValue
Enrollment Target 92 participants
Start Date 2019-01-01
Est. Completion 2023-09-30
Phase NA

Sponsor

Ceevra

3 total trials

What the Registry Record Tells You About NCT03943368

The ClinicalTrials.gov registry entry for NCT03943368 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (85% lower). The listed sponsor is Ceevra, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Ceevra Reveal is the first listed.

NCT03943368 reports 6 study locations spanning 4 distinct geographic areas - top geographies include California, Washington, Florida.

Frequently Asked Questions

What is clinical trial NCT03943368 about?

NCT03943368 is a clinical study titled "Using Virtual Reality (VR) Models for Robotic Prostatectomy". A prospective, randomized, controlled study designed to assess whether digital virtual reality (VR) models, created from existing CT scans and MRIs, provide surgeons with an improved understanding of their patients' anatomy, resulting in more efficient operations (robotic prostatectomy) and improved...

What is the current status of trial NCT03943368?

This trial is currently completed. It is a NA study. The enrollment target is 92 participants. The study started on 2019-01-01. Estimated completion is 2023-09-30.

What conditions does trial NCT03943368 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT03943368?

The interventions under investigation include: Ceevra Reveal (DEVICE).

Who is sponsoring clinical trial NCT03943368?

This trial is sponsored by Ceevra, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03943368 being conducted?

This trial has 6 study locations across California, Florida, New York, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.